Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism RABV-G inhibitors(RABV-G inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H27N3O2 |
InChIKeyWNJMKSOJWRDLLM-UHFFFAOYSA-N |
CAS Registry1309241-34-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rabies | Preclinical | US | 16 Jun 2020 |